Psychiatry | Page 10 of 60 | Links Medicus Content Curation & Alerts in Medicine

Work affects #MentalHealth & well-being.

1 in 6 working-age adults are estimated to have a mental disorder.

Globally, 12 billion working days are lost every year on account of #depression and anxiety.

? WHO recommended guidelines to protect #MentalHealthAtWork ⬇️

— World Health Organization (WHO) (@WHO) September 28, 2022

Guideline | Acute behavioral disturbance in emergency departments.

1 Nov, 2022 | 12:10h | UTC

Acute Behavioural Disturbance in Emergency Departments – Royal College of Emergency Medicine

RCT | Effectiveness of rTMS vs. bilateral Theta burst stimulation in older adults with depression.

31 Oct, 2022 | 13:38h | UTC

Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial – JAMA Psychiatry

Commentary: Neurostimulation Methods Compared for Treating Depression in Seniors – HealthDay

Commentary on Twitter

Study shows that bilateral theta-burst stimulation achieves a non-inferior reduction in #depression symptoms compared to standard bilateral rTMS, in older adults with treatment-resistant depression https://t.co/S8RZ0Ah3m0 pic.twitter.com/iAzhSj05Vf

— JAMA Psychiatry (@JAMAPsych) September 23, 2022

Retrospective Cohort Study | Association of ECMO with new mental health diagnoses in adult survivors of critical illness.

27 Oct, 2022 | 12:37h | UTC

Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness – JAMA (free for a limited period)

Editorial: Mental Health Outcomes Following Extracorporeal Membrane Oxygenation in Survivors of Critical Illness – JAMA (free for a limited period)

News Release: ECMO survivors have higher rate of new mental health diagnoses than other ICU survivors – Ottawa Hospital

Commentary from the author on Twitter (thread – click for more)

? Long-term outcomes after #ECMO are lacking in the literature.

A brief thread on our new paper in @JAMA_current, looking at mental health outcomes in survivors after ECMO (OPEN ACCESS).

Thrilled to have presented the results live @ESICM #LIVES2022 https://t.co/xaqKxCky67 pic.twitter.com/4zUomfNE7K

— Shannon Fernando (@shanfernands) October 26, 2022

Case-control study | Alcohol intake as a risk factor for acute stroke.

27 Oct, 2022 | 12:26h | UTC

Alcohol Intake as a Risk Factor for Acute Stroke: The INTERSTROKE Study – Neurology (PDF)

Commentary on Twitter

In this study, high and moderate alcohol intake were associated with increased odds of stroke, while low intake was not associated with #stroke. However, there were important regional variations. Read the full article: https://t.co/lrczN0KBmD #NeuroTwitter pic.twitter.com/95QXuwczEA

— Neurology Journal (@GreenJournal) October 19, 2022

M-A of RCT | Sleep deprivation is not effective as a treatment for major depressive episodes.

26 Oct, 2022 | 14:29h | UTC

Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis – Sleep Medicine Reviews

M-A | Non-affective psychotic disorders and risk of dementia.

26 Oct, 2022 | 14:30h | UTC

Non-affective psychotic disorders and risk of dementia: a systematic review and meta-analysis – Psychological Medicine

Commentaries:

People with schizophrenia are 2.5 times more likely to develop dementia – News Medical/University College London

Psychotic Disorders May Raise Risk for Later Dementia – HealthDay

M-A | Non-pharmacologic and pharmacologic treatments for anxiety in long-term care.

26 Oct, 2022 | 14:26h | UTC

Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis – Age and Ageing

RCT | Effect of a novel brief motivational intervention for alcohol-intoxicated young adults in the emergency department.

25 Oct, 2022 | 13:18h | UTC

Effect of a Novel Brief Motivational Intervention for Alcohol-Intoxicated Young Adults in the Emergency Department: A Randomized Clinical Trial – JAMA Network Open

Systematic Review | Antipsychotic polypharmacy reduction vs. polypharmacy continuation for people with schizophrenia.

25 Oct, 2022 | 13:12h | UTC

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia – Cochrane Library

Summary: Reduction in the number of antipsychotics for people with schizophrenia – Cochrane Library

Cohort Study | Women with schizophrenia-spectrum disorders are at increased risk of relapse after menopause.

24 Oct, 2022 | 13:59h | UTC

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse – Schizophrenia Bulletin

Commentary on Twitter

cohort study: Starting at age 45–50, women were consistently more often hospitalized for psychosis than their male peers. Women ≥45 had significantly higher aHRs than women <45 at antipsychotic monotherapy >0.6 DDDs/day, and than men at >1.1 DDDs/day https://t.co/YYINatGD0O pic.twitter.com/7xWmAnt72q

— PfOL (@psychopharmacol) October 7, 2022

RCT | No benefit from an evidence-based educational intervention for reducing coercive measures in psychiatric hospitals.

24 Oct, 2022 | 13:57h | UTC

An Evidence-Based Educational Intervention for Reducing Coercive Measures in Psychiatric Hospitals: A Randomized Clinical Trial – JAMA Network Open

Commentary: Education Program Had Limited Effect on Coercive Practices in Psych Hospitals – MedPage Today (free registration required)

Commentary on Twitter

Although feasible, the evidence-based educational intervention had a limited effect on the change of occurrence rate of patient seclusion in psychiatric hospitals. #OpenAccess #Research https://t.co/1a0BNshL0S

— JAMA Network Open (@JAMANetworkOpen) August 30, 2022

M-A | Efficacy and safety of ketamine vs. electroconvulsive therapy among patients with major depressive episode.

20 Oct, 2022 | 12:30h | UTC

Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis – JAMA Psychiatry (free for a limited period)

Commentary: Electroshock therapy is more successful for treating depression than ketamine, says study – University of Connecticut

Commentary on Twitter

While #ElectroconvulsiveTherapy may be more efficacious than #ketamine for #depression severity in the acute phase, treatment options should be individualized and patient-centered. https://t.co/4poayVgsTG

— JAMA Psychiatry (@JAMAPsych) October 19, 2022

Cohort Study | Association of hyperopia with incident clinically significant depression.

20 Oct, 2022 | 12:18h | UTC

Association of hyperopia with incident clinically significant depression: epidemiological and genetic evidence in the middle-aged and older population – British Journal of Ophthalmology

Commentary: Older Individuals with Hyperopia More Likely to Develop Incident Depression – HCP Live

M-A | Interventions associated with reduced loneliness and social isolation in older adults.

19 Oct, 2022 | 14:22h | UTC

Interventions Associated With Reduced Loneliness and Social Isolation in Older Adults: A Systematic Review and Meta-analysis – JAMA Network Open

Loneliness and health – Nature Reviews Disease Primers (if the link is paywalled, try this one)

AHA Scientific Statement | Effects of objective and perceived social isolation on cardiovascular and brain health.

The prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ

Social Isolation and Loneliness – World Health Organization

Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020 – JAMA

Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women – Heart

Phase 2 RCT | Efficacy of adjunctive D-Cycloserine to intermittent theta-burst stimulation for major depressive disorder.

19 Oct, 2022 | 14:16h | UTC

Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial – JAMA Psychiatry (link to abstract – $ for full-text)

Commentaries:

Effectiveness of iTBS for Major Depression May Be Improved by Addition of D-Cycloserine – Psychiatric News Alert

Adjunctive D-Cycloserine Improves Efficacy of Brain Stimulation in Patients with MDD – Consultant 360

Commentary on Twitter

In this RCT w 50 participants, those receiving intermittent theta-burst stimulation w adjunctive D-Cycloserine had significantly greater improvements in depressive symptoms compared to stimulation w placebo. https://t.co/AnP93WnkdG #Research

— JAMA Psychiatry (@JAMAPsych) October 12, 2022

Cohort Study | Association of attention-deficit/hyperactivity disorder diagnosis with adolescent quality of life.

18 Oct, 2022 | 12:48h | UTC

Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life – JAMA Network Open

Commentary on Twitter

Adolescents with an ADHD diagnosis reported similar quality of life overall and on 3 subdomains but worse outcomes for 5 other aspects of quality of life compared adolescents with similar levels of hyperactive/inattentive behaviors but no ADHD diagnosis. https://t.co/5o0MNfEzjD

— JAMA Network Open (@JAMANetworkOpen) October 13, 2022

RCT | A low-intensity psychosocial intervention improved recovery from depression in older adults in Brazil.

14 Oct, 2022 | 14:09h | UTC

A task-shared, collaborative care psychosocial intervention for improving depressive symptomatology among older adults in a socioeconomically deprived area of Brazil (PROACTIVE): a pragmatic, two-arm, parallel-group, cluster-randomised controlled trial – The Lancet Health Longevity

Invited Commentary: Empowering older adults and their communities to cope with depression in resource-limited settings – The Lancet Health Longevity

Commentary on Twitter

Empowering older adults and their communities to cope with #depression in resource-limited settings https://t.co/8GShpxpcOX @clausuemoto #Geriatrics

Our commentary @LancetLongevity about the incredible PRO-ACTIVE intervention by @scazufca & cols https://t.co/x2UerUFAYY pic.twitter.com/IP0DqTmGdP

— Marlon Aliberti (@marlon_aliberti) October 3, 2022